Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective
| Autor: | Marco Biolcati, Alessandro Maloberti, Matteo Palazzini, Valentina Giani, Laura Garatti, Iside Cartella, Claudio Rossetti, Massimiliano Monticelli, Filippo Leidi, Giacomo Ruzzenenti, Cristina Giannattasio, Nicola Ughi, Enzo Grasso, Oscar Massimiliano Epis |
|---|---|
| Přispěvatelé: | Ruzzenenti, G, Maloberti, A, Giani, V, Biolcati, M, Leidi, F, Monticelli, M, Grasso, E, Cartella, I, Palazzini, M, Garatti, L, Ughi, N, Rossetti, C, Epis, O, Giannattasio, C |
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Myocarditis COVID-19 Vaccines Coronaviru Myocarditi Inflammation Disease Review Article Acute myocardial infarction Cardiovascular Cardiovascular System 03 medical and health sciences 0302 clinical medicine Immune system Pharmacotherapy Internal Medicine medicine Humans Myocardial infarction Intensive care medicine business.industry SARS-CoV-2 Vaccination COVID-19 medicine.disease Prognosis Telemedicine Pulmonary embolism Coronavirus 030104 developmental biology Cardiovascular Diseases Host-Pathogen Interactions Damages medicine.symptom Cardiology and Cardiovascular Medicine business 030217 neurology & neurosurgery |
| Zdroj: | High Blood Pressure & Cardiovascular Prevention |
| ISSN: | 1179-1985 |
| Popis: | SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies have been observed, with special attention to cardiac arrhythmias and myocardial involvement. Furthermore, indirect damages determined by the reduction in acute and chronic cardiovascular care, results in a strong mortality and morbidity outcomes in cardiological patients. In this review we will summarise current knowledge on both direct and indirect cardiovascular damages determined by the SARS-CoV-2 pandemia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink